. . "These ailments might be helped by a drug that curbs inflammation by reducing the sensitivity of IKK. Still other diseases that are characterized by a weak inflamm...New drug could reduce tissue damage after heart attack..., strokes and chronic illnesses such as rheumatoid arthritis and Crohn's disease." . . . .